{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T09:18:27Z","timestamp":1792919907684,"version":"4.5.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":1803,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","exphem.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.exphem.2017.04.002","type":"journal-article","created":{"date-parts":[[2017,4,12]],"date-time":"2017-04-12T19:03:20Z","timestamp":1492023800000},"page":"7-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Adult T-type lymphoblastic lymphoma: Treatment advances and prognostic indicators"],"prefix":"10.1016","volume":"51","author":[{"given":"St\u00e9phane","family":"Lepretre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Graux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Touzart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Macintyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Boissel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2017.04.002_bib1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/ejh.12722","article-title":"Lymphoblastic lymphoma: An updated review on biology, diagnosis, and treatment","volume":"96","author":"Bassan","year":"2016","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.exphem.2017.04.002_bib2","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/PPO.0b013e31826b1232","article-title":"Adult lymphoblastic lymphoma","volume":"18","author":"Portell","year":"2012","journal-title":"Cancer J"},{"key":"10.1016\/j.exphem.2017.04.002_bib3","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1097\/00000478-200011000-00003","article-title":"Precursor B-cell lymphoblastic lymphoma: A predominantly extranodal tumor with low propensity for leukemic involvement","volume":"24","author":"Lin","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.exphem.2017.04.002_bib4","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.critrevonc.2010.12.003","article-title":"Lymphoblastic lymphoma","volume":"79","author":"Cortelazzo","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.exphem.2017.04.002_bib5","first-page":"1015","article-title":"Treatment of lymphoblastic lymphoma in adults","volume":"23","author":"Sweetenham","year":"2009","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.exphem.2017.04.002_bib6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.semcancer.2013.12.001","article-title":"Lymphoma development in patients with autoimmune and inflammatory disorders\u2014What are the driving forces?","volume":"24","author":"Baecklund","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.exphem.2017.04.002_bib7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","article-title":"Lymphoma incidence patterns by WHO subtype in the United States, 1992\u20132001","volume":"107","author":"Morton","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.04.002_bib8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ajim.4700230207","article-title":"Evaluation of risks for non-Hodgkin's lymphoma by occupation and industry exposures from a case\u2013control study","volume":"23","author":"Blair","year":"1993","journal-title":"Am J Ind Med"},{"key":"10.1016\/j.exphem.2017.04.002_bib9","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1158\/1078-0432.CCR-07-1927","article-title":"T cell receptor genotyping and HOXA\/TLX1 expression define three T lymphoblastic lymphoma subsets which might affect clinical outcome","volume":"14","author":"Baleydier","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2017.04.002_bib10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1535-6108(02)00018-1","article-title":"Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia","volume":"1","author":"Ferrando","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2017.04.002_bib11","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1365-2141.2011.08788.x","article-title":"Chromosome abnormalities in advanced stage T-cell lymphoblastic lymphoma of children and adolescents: A report from Japanese Paediatric Leukaemia\/Lymphoma Study Group (JPLSG) and review of the literature","volume":"154","author":"Sekimizu","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2017.04.002_bib12","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1200\/JCO.2011.39.7661","article-title":"Clinical impact of NOTCH1 and\/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphoma","volume":"30","author":"Callens","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2017.04.002_bib13","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/path.2789","article-title":"Notch signalling in T-cell lymphoblastic leukaemia\/lymphoma and other haematological malignancies","volume":"223","author":"Aster","year":"2011","journal-title":"J Pathol"},{"key":"10.1016\/j.exphem.2017.04.002_bib14","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1200\/JCO.2015.64.7156","article-title":"When to treat adults like children: optimizing therapy for lymphoblastic lymphoma in young adults","volume":"34","author":"O'Dwyer","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2017.04.002_bib15","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/gcc.20924","article-title":"T-Cell lymphoblastic lymphoma shows differences and similarities with T-cell acute lymphoblastic leukemia by genomic and gene expression analyses","volume":"50","author":"Basso","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.exphem.2017.04.002_bib16","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMra023001","article-title":"Acute lymphoblastic leukemia","volume":"350","author":"Pui","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2017.04.002_bib17","doi-asserted-by":"crossref","first-page":"e2014073","DOI":"10.4084\/mjhid.2014.073","article-title":"Diagnosis and subclassification of acute lymphoblastic leukemia","volume":"6","author":"Chiaretti","year":"2014","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.exphem.2017.04.002_bib18","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.04.002_bib19","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1182\/blood.V57.6.1105.1105","article-title":"Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: Evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma","volume":"57","author":"Bernard","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.04.002_bib20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/pbc.20550","article-title":"Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma","volume":"47","author":"Raetz","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.exphem.2017.04.002_bib21","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/1097-0142(197608)38:2<964::AID-CNCR2820380248>3.0.CO;2-V","article-title":"Malignant lymphoma, lymphoblastic","volume":"38","author":"Nathwani","year":"1976","journal-title":"Cancer"},{"key":"10.1016\/j.exphem.2017.04.002_bib22","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1200\/JCO.2008.19.3367","article-title":"Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: A report from the Berlin\u2013Frankfurt\u2013Muenster group","volume":"27","author":"Burkhardt","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2017.04.002_bib23","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1002\/1097-0142(19811201)48:11<2347::AID-CNCR2820481102>3.0.CO;2-X","article-title":"Lymphoblastic lymphoma: A clinicopathologic study of 95 patients","volume":"48","author":"Nathwani","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.exphem.2017.04.002_bib24","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1200\/JCO.1992.10.7.1078","article-title":"Prognosis and treatment of lymphoblastic lymphoma in adults: A report on 80 patients","volume":"10","author":"Morel","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2017.04.002_bib25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/10428199909145953","article-title":"Non-Hodgkin's lymphoma protocols in the treatment of patients with Burkitt's lymphoma and lymphoblastic lymphoma: A report on 58 patients","volume":"36","author":"Kaiser","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.exphem.2017.04.002_bib26","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/oxfordjournals.annonc.a059214","article-title":"Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt's lymphomas in adult patients","volume":"6","author":"Jost","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1016\/j.exphem.2017.04.002_bib27","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1200\/JCO.1986.4.11.1628","article-title":"Treatment of lymphoblastic lymphoma in adults","volume":"4","author":"Coleman","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2017.04.002_bib28","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/sj.leu.2403095","article-title":"Adult lymphoblastic lymphoma: A retrospective analysis of 92 patients under 61 years included in the LNH87\/93 trials","volume":"17","author":"Le Gouill","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2017.04.002_bib29","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1182\/blood-2002-01-0110","article-title":"Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia","volume":"99","author":"Hoelzer","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.04.002_bib30","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1182\/blood-2003-12-4428","article-title":"Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma","volume":"104","author":"Thomas","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.04.002_bib31","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3109\/0284186X.2014.889850","article-title":"Treatment outcome in T-cell lymphoblastic lymphoma in adults: A population-based study from the Swedish Lymphoma Registry","volume":"53","author":"Ellin","year":"2014","journal-title":"Acta Oncol"},{"key":"10.1016\/j.exphem.2017.04.002_bib32","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/annonc\/mdl426","article-title":"Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomes","volume":"18","author":"Song","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.exphem.2017.04.002_bib33","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3109\/0284186X.2013.855816","article-title":"Multimodal treatment with ALL-like chemotherapy, auto-SCT and radiotherapy for lymphoblastic lymphoma","volume":"53","author":"Bersvendsen","year":"2014","journal-title":"Acta Oncol"},{"key":"10.1016\/j.exphem.2017.04.002_bib34","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1023\/A:1008202808144","article-title":"Role of induction chemotherapy and bone marrow transplantation in adult lymphoblastic lymphoma: A report on 62 patients from a single center","volume":"9","author":"Bouabdallah","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1016\/j.exphem.2017.04.002_bib35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00277-011-1252-x","article-title":"Results of a lymphoblastic leukemia-like chemotherapy program with risk-adapted mediastinal irradiation and stem cell transplantation for adult patients with lymphoblastic lymphoma","volume":"91","author":"Cortelazzo","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.exphem.2017.04.002_bib36","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1200\/JCO.2015.61.5385","article-title":"Pediatric-like acute lymphoblastic leukemia therapy in adults with lymphoblastic lymphoma: The GRAALL-LYSA LL03 Study","volume":"34","author":"Lepretre","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2017.04.002_bib37","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1182\/blood.V124.21.370.370","article-title":"Favorable outcome in a large cohort of prospectively treated adult patients with T-lymphoblastic lymphoma (T-LBL) despite slowly evolving complete remission assessed by conventional radiography","volume":"124","author":"G\u00f6kbuget","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.04.002_bib38","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1200\/JCO.2003.02.053","article-title":"Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials","volume":"21","author":"Boissel","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2017.04.002_bib39","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ajh.23149","article-title":"Adolescents and young adults with acute lymphoblastic leukemia have a better outcome when treated with pediatric-inspired regimens: Systematic review and meta-analysis","volume":"87","author":"Ram","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.exphem.2017.04.002_bib40","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1200\/JCO.2007.13.7265","article-title":"Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Espanol de Tratamiento en Hematologia pediatric-based protocol ALL-96","volume":"26","author":"Ribera","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2017.04.002_bib41","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1182\/blood-2008-01-130237","article-title":"What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies","volume":"112","author":"Stock","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.04.002_bib42","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1200\/JCO.2008.18.6916","article-title":"Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: The GRAALL-2003 study","volume":"27","author":"Huguet","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2017.04.002_bib43","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s11899-014-0210-9","article-title":"Pediatric-like therapy for adults with ALL","volume":"9","author":"Dombret","year":"2014","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.exphem.2017.04.002_bib44","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/leu.2014.229","article-title":"Long-term outcome of a pediatric-inspired regimen used for adults aged 18\u201350 years with newly diagnosed acute lymphoblastic leukemia","volume":"29","author":"DeAngelo","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2017.04.002_bib45","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1002\/cncr.10552","article-title":"The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphoma","volume":"94","author":"Dabaja","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.exphem.2017.04.002_bib46","first-page":"416","article-title":"Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: A BFM group report","volume":"95","author":"Reiter","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.04.002_bib47","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1200\/JCO.1994.12.7.1358","article-title":"High-dose therapy and autologous bone marrow transplantation for adult patients with lymphoblastic lymphoma: Results of the European Group for Bone Marrow Transplantation","volume":"12","author":"Sweetenham","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2017.04.002_bib48","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1182\/blood-2002-05-1483","article-title":"A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma","volume":"101","author":"Levine","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.04.002_bib49","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.bbmt.2005.07.001","article-title":"Chemotherapy and hematopoietic stem cell transplantation for adult T-cell lymphoblastic lymphoma: Current status and controversies","volume":"11","author":"Aljurf","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.exphem.2017.04.002_bib50","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1200\/JCO.2001.19.11.2927","volume":"19","author":"Sweetenham","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2017.04.002_bib51","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrclinonc.2015.187","article-title":"Novel immunotherapies in lymphoid malignancies","volume":"13","author":"Batlevi","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.exphem.2017.04.002_bib52","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1182\/blood-2006-11-056754","article-title":"Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801","volume":"109","author":"DeAngelo","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.04.002_bib53","article-title":"A childhood chemotherapy protocol improves overall survival among adults with T-lymphoblastic lymphoma","author":"Zhu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.exphem.2017.04.002_bib54","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/10428199409049726","article-title":"Long-term follow-up of a CHOP-based regimen with maintenance therapy and central nervous system prophylaxis in lymphoblastic non-Hodgkin's lymphoma","volume":"15","author":"Colgan","year":"1994","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.exphem.2017.04.002_bib55","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/sj.leu.2404156","article-title":"High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL)","volume":"20","author":"Jabbour","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2017.04.002_bib56","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s13277-013-0647-9","article-title":"High levels of bcl-2 protein expression do not correlate with genetic abnormalities but predict worse prognosis in patients with lymphoblastic lymphoma","volume":"34","author":"Gu","year":"2013","journal-title":"Tumour Biol"},{"key":"10.1016\/j.exphem.2017.04.002_bib57","first-page":"680","volume":"45","author":"Hu","year":"2014","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.exphem.2017.04.002_bib58","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1309\/AJCPMF03LVSBLHPJ","article-title":"T-lymphoblastic leukemia\/lymphoma","volume":"144","author":"You","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.exphem.2017.04.002_bib59","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3324\/haematol.2009.007526","article-title":"Frequency and clinical relevance of DNA microsatellite alterations of the CDKN2A\/B, ATM and p53 gene loci: A comparison between pediatric precursor T-cell lymphoblastic lymphoma and T-cell lymphoblastic leukemia","volume":"95","author":"Krieger","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2017.04.002_bib60","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/sj.leu.2404275","article-title":"Loss of heterozygosity on chromosome 6q14-q24 is associated with poor outcome in children and adolescents with T-cell lymphoblastic lymphoma","volume":"20","author":"Burkhardt","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2017.04.002_bib61","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/10428190701824551","article-title":"Pediatric precursor T lymphoblastic leukemia and lymphoblastic lymphoma: Differences in the common regions with loss of heterozygosity at chromosome 6q and their prognostic impact","volume":"49","author":"Burkhardt","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.exphem.2017.04.002_bib62","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1182\/blood-2008-10-184069","article-title":"NOTCH1\/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): A Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study","volume":"113","author":"Asnafi","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.04.002_bib63","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1182\/blood-2011-02-334219","article-title":"Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1\/FBXW7 mutations, but not of low ERG\/BAALC expression: A GRAALL study","volume":"118","author":"Ben Abdelali","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.04.002_bib64","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1200\/JCO.2012.48.5292","article-title":"Toward a NOTCH1\/FBXW7\/RAS\/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: A Group for Research in Adult Acute Lymphoblastic Leukemia study","volume":"31","author":"Trinquand","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2017.04.002_bib65","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1182\/blood-2007-06-097238","article-title":"The role of FDG-PET scans in patients with lymphoma","volume":"110","author":"Seam","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.04.002_bib66","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1200\/JCO.2008.21.1318","article-title":"Minimal disseminated disease in childhood T-cell lymphoblastic lymphoma: A report from the Children's Oncology Group","volume":"27","author":"Coustan-Smith","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2017.04.002_bib67","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1002\/pbc.25607","article-title":"Detection and role of minimal disseminated disease in children with lymphoblastic lymphoma: The AIEOP experience","volume":"62","author":"Mussolin","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.exphem.2017.04.002_bib68","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1053\/j.seminhematol.2012.04.009","article-title":"An historic perspective of proteasome inhibition","volume":"49","author":"Esseltine","year":"2012","journal-title":"Semin Hematol"},{"key":"10.1016\/j.exphem.2017.04.002_bib69","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/bjh.14505","article-title":"The combination of bortezomib with chemotherapy to treat relapsed\/refractory acute lymphoblastic leukaemia of childhood","volume":"176","author":"Bertaina","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2017.04.002_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17474086.2017.1262757","article-title":"Nelarabine in the treatment of pediatric and adult patients with T-cell acute lymphoblastic leukemia and lymphoma","volume":"10","author":"Kadia","year":"2017","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.exphem.2017.04.002_bib71","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1200\/JCO.2005.03.426","article-title":"Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: A report from the Children's Oncology Group","volume":"23","author":"Berg","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2017.04.002_bib72","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1080\/14656566.2016.1250884","article-title":"Treating adults with acute lymphocytic leukemia: New pharmacotherapy options","volume":"17","author":"Thomas","year":"2016","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.exphem.2017.04.002_bib73","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/ajh.23167","article-title":"Clofarabine-based chemotherapy for relapsed\/refractory adult acute lymphoblastic leukemia and lymphoblastic lymphoma: The Spanish experience","volume":"87","author":"Barba","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.exphem.2017.04.002_bib74","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s10637-014-0102-9","article-title":"Pharmacology, immunogenicity, and efficacy of a novel pegylated recombinant Erwinia chrysanthemi-derived L-asparaginase","volume":"32","author":"Chien","year":"2014","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.exphem.2017.04.002_bib75","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1586\/17474086.2016.1142370","article-title":"Asparaginase Erwinia chrysanthemi as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia who have developed hypersensitivity to E. coli-derived asparaginase","volume":"9","author":"Figueiredo","year":"2016","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.exphem.2017.04.002_bib76","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1365-2141.2011.08588.x","article-title":"L-asparaginase loaded red blood cells in refractory or relapsing acute lymphoblastic leukaemia in children and adults: Results of the GRASPALL 2005-01 randomized trial","volume":"153","author":"Domenech","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2017.04.002_bib77","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/ajh.24093","article-title":"A phase 2 study of L-asparaginase encapsulated in erythrocytes in elderly patients with Philadelphia chromosome negative acute lymphoblastic leukemia: The GRASPALL\/GRAALL-SA2-2008 study","volume":"90","author":"Hunault-Berger","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.exphem.2017.04.002_bib78","doi-asserted-by":"crossref","first-page":"OF3","DOI":"10.1158\/2159-8290.CD-NB2016-159","article-title":"News in brief: Notch inhibitor shows modest efficacy","volume":"7","year":"2017","journal-title":"Cancer Discov"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X17301340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X17301340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T01:26:49Z","timestamp":1654910809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X17301340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":78,"alternative-id":["S0301472X17301340"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2017.04.002","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adult T-type lymphoblastic lymphoma: Treatment advances and prognostic indicators","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2017.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}